These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5527463)

  • 21. [A comparative clinical investigation of the diuretic furosemide].
    Schnitzler R; Fritz KW
    Arzneimittelforschung; 1966 May; 16(5):630-4. PubMed ID: 6014430
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of headache by dehydration with the saluretic Lasex].
    Simonyi J; Bálint S
    Orv Hetil; 1968 Jan; 109(4):198-9. PubMed ID: 5678048
    [No Abstract]   [Full Text] [Related]  

  • 23. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The kidney and diuretics].
    Mampel E; Koall W; Luci V
    Z Gesamte Inn Med; 1980 Sep; 35(17):Suppl 66-9. PubMed ID: 7467586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of acute hypercalcemia with furosemide].
    Baguet JC; Rampon S; Bussière JL; Sauvezie B; Gontier Y; Flori B; Doly J; Neury N; Janny P
    Rev Rhum Mal Osteoartic; 1972 Sep; 39(8):531-5. PubMed ID: 5084224
    [No Abstract]   [Full Text] [Related]  

  • 26. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current aspects of diuretic use].
    Triebe G
    Z Arztl Fortbild (Jena); 1984; 78(23):977-83. PubMed ID: 6528641
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frusemide in severe renal insufficiency.
    Muth RG
    Postgrad Med J; 1971 Apr; 47():Suppl:21-5. PubMed ID: 5579765
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diuretic therapy of cardiac insufficiency using furosemide (Lasix) and chlorthalidone (Hygroton) in children with rheumatic cardiopathies].
    Bojkinov I; Usunova T
    Arch Kinderheilkd; 1971 Jan; 82(2):115-27. PubMed ID: 5540675
    [No Abstract]   [Full Text] [Related]  

  • 31. [Demonstration of the sodium-eliminating effect of ethacrynic acid in rats].
    Senft G; Losert W; Lübbemeier A
    Arzneimittelforschung; 1968 May; 18(5):563-7. PubMed ID: 5755883
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhanced natriuretic response after hypertonic NaCl infusion into splanchnic area of anesthetized dogs.
    Zubiaur M; Frutos MA; Peces R; Mombiela MT; López-Novoa JM; Hernando L
    Medicina (B Aires); 1980; 40(5):560-8. PubMed ID: 7207187
    [No Abstract]   [Full Text] [Related]  

  • 33. [Aspects of urinary water-salt excretion in chronic nephropathies].
    Migone L; Borghetti A; Franchini I; La Greca G; Novarini A
    G Clin Med; 1969 Jul; 50(7):565-77. PubMed ID: 5386460
    [No Abstract]   [Full Text] [Related]  

  • 34. [The electrolyte excreting function of the kidneys in pulmonary tuberculosis].
    Litvin LM
    Probl Tuberk; 1971; 49(2):52-6. PubMed ID: 5561921
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of prolonged use of derivatives of the pyrazolone group on the partial functions of kidneys and on water-salt metabolism].
    Ratnikov VI
    Farmakol Toksikol; 1968; 31(3):305-8. PubMed ID: 5698111
    [No Abstract]   [Full Text] [Related]  

  • 36. Diuretic effect and duration of action of a single intravenous dose of furosemide in uremia and myocardial infarction.
    Farghali H; Al Zuhair H; Al Windawi S; Al Hamdi A; Fariduddin M
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):659-64. PubMed ID: 6526541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [RENAL HEMODYNAMICS, WATER AND ELECTROLYTE ELIMINATION AFTER 4-CHLORO-N-(2-FURYLETHYL)-5-SULFAMOYLANTHRANILIC ACID].
    HEIDLAND A; KLUETSCH K; SUZUKI F
    Arzneimittelforschung; 1964 Jun; 14():713-6. PubMed ID: 14252669
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of the site of action of oral diuretics in the human kidney.
    Lant AF; Baba WI; Wilson GM
    Clin Sci; 1967 Aug; 33(1):11-27. PubMed ID: 6059292
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of furosemide on water, electrolytes, titrable acid excretion, osmolar clearance, free water excretion, urine pH and G.F.R. in normal human subjects].
    Berker F; Bostanci N; Alhan MA; Oner M; Efe F
    Tip Fak Mecm; 1966; 29(3):472-86. PubMed ID: 5966839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.